Brought to you by 
Helix BioMedix closes $2.6mm private financing
25 Apr 2006
Executive Summary
Helix BioMedix (developing bioactive peptides for use in topical anti-infectives, wound healing, and dermatological and respiratory conditions) has raised $2.6mm with the private placement of 2.6mm common shares priced at $1 each, a 14% premium. Investors received five-year warrants to buy another 260k common shares with the exercise price of $1.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Helix BioMedix closes $2.6mm private financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice